Oakrum Pharma, LLC, a St. Louis based corporation, officially formed its U.S. Pharmaceutical business on October 4, 2018 when it received its certificate of registration in the state of Missouri.
Oakrum Pharma hired Marco Polizzi, a seasoned brand and generic pharma industry veteran, to lead the formation and development of this new business entity. The launch of Oakrum Pharma is an effort to bring more affordable medicines to a patient population that has been underserved due to its small size and unique needs. Through a business model of collaborating with experts in various disciplines and leveraging its global network of business partners, Oakrum Pharma intends to provide more options to the specialty and rare disease marketplace.
About Oakrum Pharma LLC
Oakrum Pharma, LLC is a privately-owned biopharmaceutical company focusing on the development and commercialization of affordable drug therapies for rare diseases and specialty products with significant unmet needs. For more information, visit www.Oakrumpharma.com